Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6451b3dd29c3fe40df0535433b7b0d05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_553def578e0bd020727af4c3393ea578 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42a069fc548a10dfff7c364fa39a5f91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7344c338c73789548f6209a2f32e9cea |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0663 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 |
filingDate |
2005-06-29^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-04-17^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_144114814c25c4a5360b855156de58cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34d491003ec5c3940763b8ab2c67aefa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96b1ee748a017d4d8119b57274e4e90d |
publicationDate |
2012-04-17^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8158118-B2 |
titleOfInvention |
Mesenchymal precursor cell |
abstract |
A method of enriching mesenchymal precursor sells including the step of enriching for cells based on at least two markers. The markers may be either i) the presence of markers specific for mesenchymal precursor cells, ii) the absence of markers specific for differentiated mesenchymal cells, or iii) expression levels of markers specific for mesenchymal precursor cells. The method may include a first solid phase sorting step utilizing MACS recognizing expression of the antigen to the STRO-1 Mab, followed by a second sorting step utilizing two color FACS to screen for the presence of high level STRO-1 antigen expression as well as the expression of VCAM-1. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9175267-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9169466-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011223668-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006286077-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010098671-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006193840-A1 |
priorityDate |
1999-07-07^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |